| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5601889 | European Journal of Vascular and Endovascular Surgery | 2017 | 7 Pages |
Abstract
Further randomised trials, like BASIL-2 and BEST-CLI, are required to determine whether patients with severe limb ischaemia who require IP revascularisation and who are suitable for VB should have bypass or endovascular intervention as their primary revascularisation procedure.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
M.A. Popplewell, H.O.B. Davies, J. Narayanswami, M. Renton, A. Sharp, G. Bate, S. Patel, J. Deeks, A.W. Bradbury,